COVID Misinformation: Hydroxychloroquine, Bleach Injection, UV Light Promotion
What happened:Trump repeatedly promoted hydroxychloroquine in White House briefings before studies established it was ineffective and potentially dangerous for COVID. He suggested at an April 23, 2020 briefing that injecting disinfectants might work as treatment and asked officials to study inserting UV light 'inside the body.' Governors reported hundreds of calls to poison centers and state health hotlines after the disinfectant comments. The FDA granted hydroxychloroquine an Emergency Use Authorization in March 2020 under White House pressure, then revoked it in June 2020 citing 'serious cardiac adverse events.' His false '35% mortality improvement' claim for convalescent plasma prompted FDA Commissioner Stephen Hahn to issue a correction the same day.
Corrected : Regraded from Critical Rights and Rule-of-Law Concern to Significant Democratic Concern. Unsourced '65 times' count and 'campaign donors funded oleander studies' claim removed; oleandrin passage restated to the documented July 2020 meeting and August 2020 FDA rejection; poison-centre claim narrowed to governors' reports; fabricated source links replaced.
At a glance
- Incident
- Last editorial review of this record
- Not separately recorded
- Trump repeatedly promoted hydroxychloroquine at White House briefings before the drug's limitations for COVID were established; the drug had known serious cardiac risks; the FDA granted an Emergency Use Authorization in March 2020 under White House pressure and revoked it in June 2020
- At an April 23, 2020 White House briefing, Trump suggested aloud: 'I see the disinfectant that knocks it out in a minute... is there a way we can do something like that, by injection inside, or almost a cleaning?' Lysol and Dettol both issued statements warning people not to ingest their products; poison control centers reported a national spike in disinfectant-related calls in the 24 hours following
- At the same April 23 briefing, Trump asked officials to study whether ultraviolet light could work 'inside the body' to kill the virus; Trump later claimed he was being 'sarcastic' — the video of the briefing shows no indication of sarcasm
More key points (3)
- In a July 2020 Oval Office meeting, HUD Secretary Ben Carson and MyPillow CEO Mike Lindell, an investor in a company developing oleandrin, promoted the oleander extract as a COVID treatment, and Trump expressed enthusiasm for it; it had no clinical trial data for COVID, and on August 14, 2020 the FDA rejected the manufacturer's application to market it as a dietary supplement
- When the FDA granted an Emergency Use Authorization for convalescent plasma on August 23, 2020, Trump claimed it showed '35 percent improvement in mortality'; FDA Commissioner Stephen Hahn stated on the same day that the figure was incorrect and the actual data showed a different (lower) benefit; Hahn later said he had 'made an error'
- Trump publicly attacked his own FDA in tweets for moving 'too slowly' on vaccine and treatment approvals, and his chief of staff Mark Meadows pressured FDA officials; the FDA's career staff later described White House interference in their regulatory process
Who was affected?
Americans who took hydroxychloroquine without clinical indication based on presidential promotion; cardiac patients whose hydroxychloroquine supplies were disrupted; people who ingested disinfectants following the briefing comments; public health credibility damaged during critical pandemic period
Legal context in this record
Reported.
The archive’s assessment is not a court finding. Docket activity does not refresh this assessment. A concluded archive record does not mean a court has resolved the matter.
Overview
The White House podium during the COVID pandemic became a venue for promoting treatments that ranged from unproven (hydroxychloroquine, convalescent plasma) to dangerous (bleach injection, UV light inside the body). The president's stated rationale was hope: "What do you have to lose?"
The answer was: cardiac arrhythmia, chemical burns, and a disrupted supply chain for drugs that immunocompromised patients actually needed.
Hydroxychloroquine
Trump promoted hydroxychloroquine repeatedly at White House briefings. The drug had established uses for lupus and rheumatoid arthritis; it also had known cardiac side effects. The FDA granted an Emergency Use Authorization in March 2020 under White House pressure, before clinical trials could establish efficacy or safety for COVID.
The trials established neither. Multiple randomized controlled trials found no benefit. The FDA revoked the EUA in June 2020 citing cardiac risk. The disruption to lupus patients' access to their medication was documented.
The Disinfectant Briefing
On April 23, 2020, the President of the United States stood before cameras and mused aloud about injecting disinfectants as a COVID treatment. He turned to the officials beside him — the director of the DHS Science and Technology Directorate — and asked whether they could look into it.
Lysol and Dettol issued public statements. Governors reported hundreds of calls to poison centers and state health hotlines. Trump claimed he had been sarcastic. The video showed no indication of sarcasm.
The FDA Pressure Pattern
The hydroxychloroquine EUA, the convalescent plasma approval, and the public attacks on FDA "slowness" documented a pattern: the White House treated the FDA as a communications vehicle for good news rather than a scientific regulator. When the FDA's data did not support the message Trump wanted to deliver, he delivered a different message and left his own FDA Commissioner to issue corrections.
Full record details and legal classification
The classification is the archive’s editorial assessment. Evidence strength, court findings and court jurisdiction are separate questions.
Record summary
Archive classification
Grade 1 of 5: Significant Democratic Concern
International crime assessment
No international crime alleged
Actions that weaken democratic institutions, suppress political participation, or restrict fundamental freedoms without reaching the threshold of a rights violation attributable to a specific victim class. Scale and definitions
- Archive record status
- Concluded
- Incident date
- Archive data changed
- Location
- Washington, D.C.
- Category
- Rule of Law
- Reported legal posture
- Reported
- Verification
- Independently verified
- Rome Statute relevance
- Not flagged. This does not establish ICC jurisdiction.
- Sources
- 5 cited
- Stable ID
trump-hydroxychloroquine-bleach-covid-misinformation- Last editorial review
- Not separately recorded
- Current record review identity
2de0d4e4c28c08d518666a367d7c1b18b2a60069fcdfc64a80c7125bff0b5e03This digest identifies the current record text and claims for an editorial review receipt. It is not itself a review or a court finding.
- Victims
- Americans who took hydroxychloroquine without clinical indication based on presidential promotion; cardiac patients whose hydroxychloroquine supplies were disrupted; people who ingested disinfectants following the briefing comments; public health credibility damaged during critical pandemic period
- Alleged responsible parties
- Donald Trump, President; repeatedly promoted unproven treatments from White House podium; pressured FDA to grant hydroxychloroquine EUA— White House
Reviewed developments
These updates require review of the underlying document, a precise citation and an explanation of what remains unresolved.
No developments have completed this separate review process for this record. The original account and its citations remain available. Inspect the technical history below.
Technical docket and archive history
Automatic notices and historical notes are retained here. Their wording, source links and capture receipts are preserved. Inclusion does not mean an underlying document or allegation has been fact-checked.
Inspect 2 source notices and historical notes
Historical archive note
Recorded:
Editorial review status was not separately recorded for this note.
Original notice and provenance
Corrected after ICC-standard legal review: unsourced '65 times' count and 'campaign donors funded oleander studies' claim removed; oleandrin passage restated to the documented July 2020 meeting and August 2020 FDA rejection; poison-centre claim narrowed to governors' reports; fabricated source links replaced.
Historical archive note
Recorded:
Editorial review status was not separately recorded for this note.
Original notice and provenance
Updated with convalescent plasma EUA incident.
Sequence of events
-
Trump begins hydroxychloroquine promotion
Trump publicly promotes hydroxychloroquine as a potential COVID treatment at a White House briefing, before any clinical trial results. He promotes it repeatedly over the following months.
-
FDA grants hydroxychloroquine Emergency Use Authorization
The FDA grants an Emergency Use Authorization for hydroxychloroquine for hospitalized COVID patients under White House pressure. Supplies for lupus and rheumatoid arthritis patients — the drug's established uses — become disrupted.
-
Trump suggests bleach injection and UV light 'inside the body'
At a White House briefing, Trump suggests injection of disinfectants and UV light inside the body as potential COVID treatments. Governors report hundreds of calls to poison centers and state hotlines. Manufacturers issue warnings. Trump claims sarcasm.
-
FDA revokes hydroxychloroquine EUA
The FDA revokes its Emergency Use Authorization for hydroxychloroquine, citing evidence the drug is 'unlikely to be effective' for COVID and poses serious cardiac risks. Multiple randomized controlled trials have found no benefit.
-
Trump claims '35% mortality improvement' for convalescent plasma — FDA corrects him
Trump overstates the convalescent plasma data at an EUA announcement. FDA Commissioner Hahn contradicts the '35%' figure the same day and issues a correction. The incident draws criticism about White House pressure on the FDA's scientific communications.
Sources
Open a source to inspect its full context. A preserved copy records captured material; it does not establish that every claim is true.
- Trump's Suggestion That Disinfectants Could Be Used to Treat Coronavirus Prompts Aggressive Pushback — The New York Times
No preserved copy is listed here. Preservation limits.
Source details and technical verification
- Original URL
- https://www.nytimes.com/2020/04/24/us/politics/trump-inject-disinfectant-bleach-coronavirus.html
No capture metadata is listed for this source.
No numbered inline reference to this source appears in the record text.
- Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine — U.S. Food and Drug Administration
No preserved copy is listed here. Preservation limits.
Source details and technical verification
No capture metadata is listed for this source.
No numbered inline reference to this source appears in the record text.
- Governors say Trump's disinfectant comments prompted hundreds of poison center calls — Vox
No preserved copy is listed here. Preservation limits.
Source details and technical verification
- Original URL
- https://www.vox.com/2020/4/26/21237525/trump-disinfectant-poison-control-calls-coronavirus
No capture metadata is listed for this source.
No numbered inline reference to this source appears in the record text.
- Trump eyes new unproven virus 'cure' promoted by Ben Carson and the CEO of MyPillow — Axios
No preserved copy is listed here. Preservation limits.
Source details and technical verification
No capture metadata is listed for this source.
No numbered inline reference to this source appears in the record text.
- Trump Pressed for Plasma Therapy. Officials Worry, Is an Unvetted Vaccine Next? — The New York Times
No preserved copy is listed here. Preservation limits.
Source details and technical verification
- Original URL
- https://www.nytimes.com/2020/09/12/us/politics/trump-coronavirus-treatment-vaccine.html
No capture metadata is listed for this source.
No numbered inline reference to this source appears in the record text.